Karim Belhadj

7PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Humoural immunology and immunochemistryHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2026
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Bastien Jamet, Shamimeh Ahrari, Sonja Zweegman

|Dec 14, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series.

Nathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro

|Mar 28, 2023
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma.

Laurent Garderet, Frederique Kuhnowski, Benoit Berge

|Sep 02, 2022
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.

Hajer Abroud, Asma Beldi-Ferchiou, Vincent Audard

|Feb 16, 2022
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.

Titouan Cazaubiel, Xavier Leleu, Aurore Perrot

|Apr 07, 2021
Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results.

Murielle Roussel, Valerie Lauwers-Cances, Soraya Wuilleme

Pageof 2

Frequent Collaborators

3 joint publications

Jill Corre

2 joint publications

Murielle Roussel

2 joint publications

Aurore Perrot

2 joint publications

Monique Minnema